Solen Kernéis

Solen Kernéis

Auto-generated profile, based on publicly available information

Solen Kernéis

Équipe de Prévention du Risque Infectieux, Hôpital Bichat - Claude Bernard AP-HP, F-75018, Paris, France; Université Paris Cité, INSERM, IAME, F-75018, Paris, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in Science
Verified
Journal Article
Open access
PDF file
JHJérôme Hadjadj
Jérôme Hadjadj
NYNader Yatim
Nader Yatim
LBLaura Barnabei
Laura Barnabei
ACAurélien Corneau
Aurélien Corneau
JBJeremy Boussier
Jeremy Boussier
BTBenjamin Terrier
Benjamin Terrier
Interferons interfere with lung repair: Interferons (IFNs) are central to antiviral immunity. Viral recognition elicits IFN production, which in turn triggers the transcription of IFN-stimulated genes (ISGs), which engage in various antiviral functions. Type I IFNs (IFN-α and IFN-β) are widely expressed and can result in immunopathology during viral infections. By contrast, type III IFN (IFN-λ) responses are primarily restricted to mucosal surfaces and are thought to confer antiviral protection without driving damaging proinflammatory responses. Accordingly, IFN-λ has been proposed as a therapeutic in coronavirus disease 2019 (COVID-19) and other such viral respiratory diseases (see the Perspective by Grajales-Reyes and Colonna). Broggi et al. report that COVID-19 patient morbidity correlates with the high expression of type I and III IFNs in the lung. Furthermore, IFN-λ secreted by dendritic cells in the lungs of mice exposed to synthetic viral RNA causes damage to the lung epithelium, which increases susceptibility to lethal bacterial superinfections. Similarly, using a mouse model of influenza infection, Major et al. found that IFN signaling (especially IFN-λ) hampers lung repair by inducing p53 and inhibiting epithelial proliferation and differentiation. Complicating this picture, Hadjadj et al. observed that peripheral blood immune cells from severe and critical COVID-19 patients have diminished type I IFN and enhanced proinflammatory interleukin-6– and tumor necrosis factor-α–fueled responses. This suggests that in contrast to local production, systemic production of IFNs may be beneficial. The results of this trio of studies suggest that the location, timing, and duration of IFN exposure are critical parameters underlying the success or failure of therapeutics for viral respiratory infections. Science , this issue p. 706 , p. 712 , p. 718 ; see also p. 626

14 July 2020 in Critical Care
Verified
Journal Article
Open access
PDF file
CMCéline Monard
Céline Monard
JPJonathan Pehlivan
Jonathan Pehlivan
GAGabriel Auger
Gabriel Auger
SASophie Alviset
Sophie Alviset
ADAlexy Tran Dinh
Alexy Tran Dinh
TUThomas Uberti
Thomas Uberti
Background: Improving timeliness of pathogen identification is crucial to allow early adaptation of antibiotic therapy and improve prognosis in patients with pneumonia. We evaluated the relevance of a new syndromic rapid multiplex PCR test (rm-PCR) on respiratory samples to guide empirical antimicrobial therapy in adult patients with community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-acquired pneumonia (VAP). Methods: This retrospective multicenter study was conducted in four French university hospitals. Respiratory samples were obtained from patients with clinical and radiological signs of pneumonia and simultaneously tested using conventional microbiological methods and the rm-PCR. A committee composed of an intensivist, a microbiologist, and an infectious diseases specialist retrospectively assessed all medical files and agreed on the most appropriate antimicrobial therapy for each pneumonia episode, according to the results of rm-PCR and blinded to the culture results. The rm-PCR-guided antimicrobial regimen was compared to the empirical treatment routinely administered to the patient in standard care. Results: We included 159 pneumonia episodes. Most patients were hospitalized in intensive care units (n = 129, 81%), and episodes were HAP (n = 68, 43%), CAP (n = 54, 34%), and VAP (n = 37, 23%). Conventional culture isolated ≥ 1 microorganism(s) at significant level in 95 (60%) patients. The syndromic rm-PCR detected at least one bacteria in 132 (83%) episodes. Based on the results of the rm-PCR, the multidisciplinary committee proposed a modification of the empirical therapy in 123 (77%) pneumonia episodes. The modification was a de-escalation in 63 (40%), an escalation in 35 (22%), and undetermined in 25 (16%) patients. In microbiologically documented episodes (n = 95), the rm-PCR increased appropriateness of the empirical therapy to 83 (87%), as compared to 73 (77%) in routine care. Conclusions: Use of a syndromic rm-PCR test has the potential to reduce unnecessary antimicrobial exposure and increase the appropriateness of empirical antibiotic therapy in adult patients with pneumonia.

1 April 2016 in Vaccine
Verified
Journal Article
Closed access
PLPaul Loubet
Paul Loubet
CGCaroline Guerrisi
Caroline Guerrisi
CTClément Turbelin
Clément Turbelin
BBBéatrice Blondel
Béatrice Blondel
OLOdile Launay
Odile Launay
SKSolen Kernéis
Solen Kernéis

14 July 2020 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
ACAdrien Contejean
Adrien Contejean
JLJérémie Leporrier
Jérémie Leporrier
ECEtienne Canouï
Etienne Canouï
FAFanny Alby-Laurent
Fanny Alby-Laurent
ELEmmanuel Lafont
Emmanuel Lafont
SKSolen Kernéis
Solen Kernéis
Background: Healthcare workers (HCWs) have paid a heavy toll during the coronavirus disease 2019 (COVID-19) outbreak. Routes of transmission remain to be fully understood.Methods: This prospective study compared a 1500-bed adult and 600-bed pediatric setting of a tertiary-care university hospital located in central Paris. From 24 February until 10 April 2020, all symptomatic HCWs were screened for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a nasopharyngeal swab. HCWs screened positive were questioned on their profession, symptoms, and occupational and nonoccupational exposures to SARS-CoV-2.Results: Among 1344 HCWs tested, 373 were positive (28%) and 336 (90%) corresponding questionnaires were completed. Three hospitalizations and no deaths were reported. Most HCWs (70%) had patient-facing occupational activities (22% in COVID-19 dedicated units). The total number of HCW cases peaked on 23 March, then decreased slowly, concomitantly with a continuous increase of compliance to preventive measures (including universal medical masking and personal protective equipment [PPE] for direct care to COVID-19 patients). Attack rates were of 3.2% and 2.3% in the adult and pediatric settings, respectively (P = .0022). In the adult setting, HCWs more frequently reported exposure to COVID-19 patients without PPE (25% vs 15%, P = .046). Report of contacts with children attending out-of-home care facilities dramatically decreased over the study period.Conclusions: Universal masking, reinforcement of hand hygiene, and PPE with medical masks for patients’ care allowed protection of HCWs and containment of the outbreak. Residual transmissions were related to persistent exposures with undiagnosed patients or colleagues and not to contacts with children attending out-of-home care facilities.

28 February 2023 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
SPSimona Presente
Simona Presente
CBChristine Bonnal
Christine Bonnal
ANAnne-Cécile Normand
Anne-Cécile Normand
YGYannick Gaudonnet
Yannick Gaudonnet
AFArnaud Fekkar
Arnaud Fekkar
SKSolen Kernéis
Solen Kernéis
We report the first identification of a fluconazole-resistant Candida parapsilosis (FR- Cp ) strain in our hospital, which subsequently caused an outbreak involving 17 patients (12 deaths) within a 26-bed French intensive care unit. Microsatellite genotyping confirmed that all FR- Cp isolates belonged to the same clone.

1 May 2017 in Joint Bone Spine
Verified
Journal Article
Closed access
MAManal Assala
Manal Assala
MGMatthieu Groh
Matthieu Groh
PBPhilippe Blanche
Philippe Blanche
CVChristine Vinter
Christine Vinter
PCPascal Cohen
Pascal Cohen
SKSolen Kernéis
Solen Kernéis